Catalyst
Slingshot members are tracking this event:
Cempra Authorized to Receive Funds From BARDA for a Phase 2/3 Clinical Trial of Solithromycin in Pediatric Patients
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
CEMP | Community voting in process |
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 07, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Barda, Solithromycin, Bacterial Infectious Diseases, Community-acquired Bacterial Pneumonia, Cabp